J 2025 Q2
Earnings Overview & AI Insights

Earnings Performance

Summary of Financial Performance:

Jacobs delivered strong Q2 2025 results, including adjusted EPS growth of 22% to $1.43, adjusted net revenue growth of 3% (4% on a constant currency basis), and adjusted EBITDA growth of 8% to $287 million. Adjusted EBITDA margin improved by 62 basis points year-over-year to 13.4%. Backlog reached a record $22.2 billion, up 20% year-over-year, with trailing 12-month book-to-bill at 1.3x. Despite absorbing the impact of a legal reserve related to a consolidated JV matter, gross profit in backlog increased 15% year-over-year. Free cash flow was negative $114 million due to seasonal timing effects, aligning with prior patterns. The company repurchased $351 million in shares and reduced debt by $312 million through an equity-for-debt transaction.

Company Outlook & Strategy:

Jacobs reaffirmed its FY 2025 guidance, projecting adjusted net revenue growth in the mid-to-high single digits, adjusted EBITDA margin of 13.8–14%, free cash flow conversion above 100%, and adjusted EPS of $5.85–$6.20. Sequential revenue growth of 5–7% is expected in Q3, supported by strong backlog visibility. The company remains focused on sustainable, profitable growth, leveraging its alignment with global mega trends and its five-year strategic plan. Capital return to shareholders remains a priority, evidenced by increased share repurchases and dividends.

Key Industry Trends:

• Water and Environmental: High global demand for water infrastructure, driven by regulations on emerging contaminants like PFAS.
• Life Sciences & Advanced Manufacturing: Double-digit growth in life sciences and data center segments, with semiconductor recovery expected in coming quarters.
• Critical Infrastructure: Rising global travel demand and energy security are driving growth in transportation and energy/power verticals.

Operational Highlights:

• Jacobs completed the separation of its former CMS and C&I businesses, reducing outstanding debt and distributing Amentum shares to shareholders.
• Notable project wins included cybersecurity solutions for Hampton Roads Sanitation District, PFAS removal upgrades for Boynton Beach, FL, engineering for Merck’s oncology facility, and support for PsiQuantum’s quantum computing data center in Australia.
• Strong growth in PA Consulting, driven by Energy & Utilities and Life Sciences, with operating profit up 12% year-over-year.

Challenges & Risks:

• Legal reserve related to a consolidated JV matter impacted adjusted net revenue and operating profit. The project is over 97% complete, and the company believes it has appropriately reserved for the matter.
• FX headwinds impacted Q2 results, reducing revenue growth by 80 basis points.
• Customer procurement cycles are extending slightly due to macroeconomic uncertainty.

Key Analyst Questions & Responses:

• Andy Kaplowitz (Citi): Asked about backlog growth and whether customer spending acceleration is needed for Q3 revenue targets. Management emphasized strong backlog visibility, which supports confidence in sequential growth. While procurement cycles are lengthening, there are no broad cancellations or delays in execution. Regarding the legal reserve, the company noted its accounting treatment and confidence in appropriate reserves.

Jacobs remains optimistic about its trajectory, citing robust backlog growth, margin expansion, and strategic alignment with high-growth markets. Management expects continued momentum in the second half of FY 2025.